Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study (Q35908862)
Jump to navigation
Jump to search
scientific article published on 9 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study |
scientific article published on 9 March 2012 |
Statements
1 reference
Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study (English)
1 reference
Cheryl McDonald
1 reference
Jonathan Uy
1 reference
Wenhua Hu
1 reference
Victoria Wirtz
1 reference
Salome Juethner
1 reference
David Butcher
1 reference
Donnie McGrath
1 reference
Awny Farajallah
1 reference
Graeme Moyle
1 reference
9 March 2012
1 reference
1 reference
259-264
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference